custom injectable semaglutide Compounded' weight-loss drugs are a growing problem for state regulators • Stateline Compounded Semaglutide/Tirzepatide: Personalized, Affordable Medical

GLP-1s mimic a hormone produced in the gut to tamp down a person's appetite and regulate their blood sugar

The complex interaction between all the factors does not allow definitive determination if OS is a primary cause or if it is a secondary effect to the propagation of damage in the nervous cells

Results published in The Lancet showed significant improvements in both weight and glycemic control (Rosenstock et al., 2023): Participants lost up to 16.9% of body weight (lower than the non-diabetic cohort, consistent with other medication studies) HbA1c reductions of up to 2.02 percentage points , bringing many participants into the normal range Significant improvements in fasting glucose and insulin sensitivity Phase 3 Trials Eli Lilly initiated Phase 3 clinical trials for retatrutide in late 2023

10.1002/ddr.21557 52

Whether used alone or combined with rapid-acting insulins or oral medications, both products demonstrate comparable efficacy in maintaining steady blood sugar levels for patients managing either type 1 or type 2 diabetes